Back to Top

OncoImmunology (OncoImmunology)

Publisher :

Taylor & Francis

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • Basic and translational studies
  • Modern immunotherapies
  • Inflammation
  • +7

e-ISSN :

2162-402X

Issue Frequency :

Continuously

Impact Factor :

6.5

Est. Year :

2012

Mobile :

4402080520500

DOI :

YES

Country :

United Kingdom

Language :

English

APC :

YES

Impact Factor Assignee :

GOOGLE SCHOLAR

Email :

enquiries@taylorandfrancis.com

Journal Descriptions

OncoImmunology is a dynamic, high-profile, open access journal broadly covering tumor immunology and immunotherapy. As cancer immunotherapy continues to evolve, OncoImmunology aims to publish high-quality, rigorous research on all aspects of basic and applied tumor immunology. Topics covered include: Basic and translational studies in immunology of both solid and hematological malignancies Inflammation, innate and acquired immune responses against cancer Mechanisms of cancer immunoediting and immune evasion Modern immunotherapies including, but not limited to, immunomodulators, immune checkpoint inhibitors, T-cell, NK-cell and macrophage engagers, and CAR T cells Immunological effects of conventional anticancer therapies. OncoImmunology operates a single-anonymized peer review policy.


OncoImmunology (OncoImmunology) is :

International, Peer-Reviewed, Open Access, Refereed, Basic and translational studies, Modern immunotherapies, Inflammation, innate, acquired immune responses against cancer, macrophage engagers, immunomodulators, immune checkpoint inhibitors, T-cell, NK-cell , Online Continuously Journal

UGC Approved, ISSN Approved: P-ISSN , E-ISSN - 2162-402X, Established in - 2012, Impact Factor - 6.5

Provide Crossref DOI

Indexed in Scopus, WoS

Not indexed in DOAJ, PubMed, UGC CARE

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile